| 國立成功大學 |
2024-12 |
Comparison of the inhibition effects of naringenin and its glycosides on LPS-induced inflammation in RAW 264.7 macrophages
|
Cho;Shu-Chi;Shaw;Shyh-Yu |
| 國立成功大學 |
2024-11-5 |
Trial in Progress: Odronextamab for the Treatment of Patients with Relapsed/Refractory Mantle Cell Lymphoma Following Prior BTK Inhibitor Therapy - a Cohort of the ELM-2 Study
|
Cho;Seok-Goo;Kim;Min, Tae;Taszner;Michal;Chen;Tsai-Yun;Choudhry;Aafia;Ufkin;Melanie;Uppala;Amulya;Sabir;Ayesha;Mohamed;Hesham;Ambati;Srikanth;Bachy;Emmanuel |
| 國立成功大學 |
2024-11-5 |
Sequential Bruton Tyrosine Kinase Inhibitor Therapy in Relapsed or Refractory Mantle Cell Lymphoma Following Chemotherapy: Real-World Outcomes and Attrition Rates- an Updated Report from the Asia-Pacific Multinational Retrospective Registry
|
Cho;Hyungwoo;Yoon;Hyun, Dok;Chan;Yongsheng, Jason;Kim;Dajung;Huang;Haiwen;Cai;Qingqing;Lin;Tongyu;Kato;Koji;Bunworasate;Udomsak;Tan;Mui, Sen;Kang;Ka-Won;Kwak;Jae-Yong;Chen;Tsai-Yun;Lee;Jeong-Ok;Jeong;Hyun, Seong;Do;Rok, Young;Chan;Esther;Kang;Jin, Hye;Uhm;Hyun-Seok;Oh;Yong, Sung;Koh;Youngil;Kim;Jung, Hyo;Kim;Hyung, Se;Won;Ho, Jong;Park;Hoon, Young;Yang;Deok-Hwan;Ng;Chin, Soo;Jo;Jae-Cheol;Kim;Seog, Won |
| 國立成功大學 |
2024-11-01 |
Production of combustible gas via incorporating CO2 to pyrolysis of medicinal herbal waste
|
Cho;Seong-Heon;Lee;Taewoo;Cha;Hoyeon;Chen;Wei-Hsin;Tsang;Fai, Yiu;Kwon;Eilhann, Eilhann E. |
| 國立成功大學 |
2024-11 |
2023 TSOC-TACVPR-TACPAH Consensus Statement of the Rehabilitation on Patients with Pulmonary Hypertension
|
Huang;Wei-Chun;Cheng;Yuan-Yang;Hsu;Chih-Hsin;Wu;Yih-Jer;Cheng;Chin-Chang;Ho;Wan-Jing;Chuang;Hung-Jui;Chu;Chun-Yuan;Lin;Ko-Long;Wang;Lin-Yi;Chiu;Yu-Wei;Chen;Kuan-Cheng;Chung;Sheng-Ying;Chen;Yi-Jen;Wu;Chun-Hsien;Chen;Ssu-Yuan;Liu;Wei-Shin;Lin;Cho-;I;Chiu;Fu-Chun;Chen;Hsin-Shui;Sung;Shih-Hsien;Chou;Li-Wei;Wu;Shu-Hao;Lin;Yen-Hung;Wu;Chun-Yi;Lin;Chiung-Hung;Lin;Ming-Chih;Hung;Cheng-Chung;Lei;Chuan, Chao;Wang;Mei-Tzu;Chen;Chia-Hsin;Chou;Willy;Hou;Charles, Jia-Yin;Chen;Wen-Jone |
| 國立成功大學 |
2024-10 |
An unidentified yet notable modification on INa and IK(DR) caused by ramelteon
|
Wu;Po-Ming;Tu;Yi-Fang;Cho;Hsin-Yen;Yu;Meng-Cheng;Wu;Yen-Hsien;Wu;Sheng-Nan |
| 國立成功大學 |
2024-10 |
Amivantamab Plus Lazertinib vs Osimertinib in First Line, EGFR-Mutant Advanced NSCLC: Patientrelevant Outcomes from MARIPOSA
|
Nguyen;D;Besse;B;Cho;B, C.;Lee;S, -H.;Lee;K, H.;Lu;S;Cheng;Y;Yao;Y;Girard;N;Lin;C, -C.;Felip;E;Aguilar;A;Charoentum;C;Cruz;F, J. S. M.;Majem;M;Lim;C, S.;Akamatsu;H;Hayashi;H;Yang;J, C. -H.;Kowalyszyn;R;Tiscoski;K;Franke;F;Ponomarenko;D;Arslan;C;Forster;M;Urban;D;Misch;D;Delmonte;A;Montes;L, V. G.;Gadgeel;S, M.;Cruz-Correa;M;Peguero;J;Rousey;S;Gaffar;Y;Owen;S;Schuchard;J;Diels;J;Sermon;J;Sun;T;Ennis;M;Fennema;E;Daksh;M;Sethi;S;Bauml;J, M.;Campelo, Garcia;M, R. |
| 國立成功大學 |
2024-09-15 |
Effective suppression of I h and I Na caused by capsazepine, known to be a blocker of TRPV1 receptor
|
Wong;Siew-Lee;Shih;-Lung, Chia;Cho;Hsin-Yen;Wu;Sheng-Nan |
| 國立成功大學 |
2024-09 |
Phase I/II ARROS-1 study of zidesamtinib (NVL-520) in ROS1 fusion-positive solid tumours
|
Besse;B;Drilon;A, E.;Cho;B, C.;Camidge;D, R.;Neal;J;Lin;C-C;Liu;S, V.;Nagasaka;M;Kao;C-H, S.;Felip;E;Wekken, Van der;A, J.;Lin;C, C. C.;Bauman;J, R.;Gadgeel;S;Samant;M;Shen;J;Sun;Y;Zhu;V, W.;Upadhyay;V, A.;Lin;J, J. J. |
| 國立成功大學 |
2024-08-1 |
The role of an in-plane electric field during the merging formation of spherical tokamak plasmas
|
Inomoto;M;Suzuki;T;Jin;H;Maeda;Y;Togo;Y;Cho;S;Tanabe;H;Ono;Y;Kawamori;E;Usami;S;Yanai;R |
